Showing results (271-280 of 309) with videos related to

Sort By:
Pageof 31
Critical Reviews in Oncology/Hematology|January 1, 1986
Current status of treatment of acute leukemia in adults: an overview of the Memorial experience and review of literatureB D Clarkson, T Gee, Z A Arlin, et al.
Blood|October 1, 1996
Topotecan, a topoisomerase I inhibitor, is active in the treatment of myelodysplastic syndrome and chronic myelomonocytic leukemiaM Beran, H Kantarjian, S O'Brien, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 1, 1995
Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasiaP Anderlini, R S Benjamin, F C Wong, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 11, 1995
Cell cycle-related shifts in subcellular localization of BCR: association with mitotic chromosomes and with heterochromatinM Wetzler, M Talpaz, G Yee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 18, 1997
CD30 ligand in lymphoma patients with CD30+ tumorsA Younes, U Consoli, V Snell, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 3, 2000
E1A-mediated paclitaxel sensitization in HER-2/neu-overexpressing ovarian cancer SKOV3.ip1 through apoptosis involving the caspase-3 pathwayN T Ueno, C Bartholomeusz, J L Herrmann, et al.
The New England Journal of Medicine|May 26, 1991
Differentiation therapy of acute promyelocytic leukemia with tretinoin (all-trans-retinoic acid)R P Warrell, S R Frankel, W H Miller, et al.
Blood|May 15, 1993
Fluorescent in situ hybridization and cytogenetic studies of trisomy 12 in chronic lymphocytic leukemiaS M Escudier, J M Pereira-Leahy, J W Drach, et al.
Cancer|June 8, 2001
Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significanceF Ravandi, H M Kantarjian, M Talpaz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 1993
Dose-escalation trial of M195 labeled with iodine 131 for cytoreduction and marrow ablation in relapsed or refractory myeloid leukemiasM A Schwartz, D R Lovett, A Redner, et al.
Pageof 31